REFERENCES
- Newman SP, Agnew JE, Pavia D, Clarke SW. Inhaled aerosols: lung depositions and clinical applications. Clin Phys Physiol Measure 1982;3:1–20
- Pedersen S. Inhalers and nebulizers: which to choose and why. Respir Med 1996;90:69–77
- Dolovich MB. Assessing nebulizer performance. Respir Care 2002;47:1290–301
- Becker A, Bérubé D, Chad Z, Dolovich M, Ducharme F, D'Urzo T, et al. Inhalation devices. CMAJ2005;173:S39-45
- Van der Palen J, Klein JJ, van Herwaarden CLA, Zielhuis GA, Seydel ER. Multiple inhalers confuse asthma patients. Eur Respir J 1999;14:1034–7
- Mandelberg A, Chen E, Noviski N, Priel IE. Nebulized wet aerosol treatment in the emergency room: is it essential? Comparison with large spacer for metered dose inhaler. Chest 1997;112:1501–5
- Mandelberg A, Tsehori S, Houri S, Gilad E, Morag B, Priel IE. Is nebulized aerosol treatment necessary in the paediatric emergency department? Chest 2000;117:1309–13
- Agertoft L, Pedersen S. Importance of training for correct Turbuhaler use in preschool children. Acta Paediatr 1998;87:842–7
- European Respiratory Society Nebulizer Guidelines: Technical Aspects. Eur Respir Rev 2000;10: Nr 72
- Chua HL, Collis GG, Newbury AM, Chau K, Boner GD, Sly PD, et al. The influence of age on aerosol deposition in children with cystic fibrosis. Eur Respir J 1994;7:2185–91
- Laube BL, Jashnani R, Dalby RN, Zeitlin PL. Targeting aerosol deposition in patients with cystic fibrosis. Chest 2000;118:1069–76
- Boe J, Dennis JH, O'Driscoll, Bauer TT, Carone M, Dautzenberg B, et al. European Respiratory Society guidelines on the use of nebulizers. Eur Respir J 2001;18:228–42
- Fink JB. Devices and equipment evaluations. Respir Care 2004;49:1157–64
- Fink JB. Aerosol device selection: evidence to practice. Respir Care 2000;45:874–85
- Garcia-Contreras L, Hickey A. Pharmaceutical and biotechnological aerosols for cystic fibrosis therapy. Adv Drug Delivery Rev 2002;54:1491–504
- Rubin BK. Nebulizer therapy for children: the device-patient interface. Respir Care 2002;47:1314–9
- Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J 2002;19:246–51
- Dolovich MB, Ahrens RC, Hess DR, Anerson P, Dhand R, Rau JL, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy and Immunology. Chest 2005;127:335–71
- Kamps AW, Brand PL, Roorda RJ. Determinants of correct inhalational technique in children attending a hospital-based asthma clinic. Acta Paediatr 2002;91:159–63
- Kamps AW, van Ewijk B, Roorda RJ, Brand PL. Poor inhalation technique even after inhalation instructions, in children. Pediatr Pulmonol 2000;29:39–42
- Chopra N, Oprescu N, Fask A, Oppenheimer J. Does introduction of new 'easy to use' inhalation devices improve medical personnel's knowledge of their proper use? Ann Allergy Asthma Immunol 2002;88:395–400
- Iles R, Lister P, Edmunds AT. Crying significantly reduces absorption of aerosolized drug in infants. Arch Dis Child 1999;81:163–5
- Hakkinene AM, Uusi-Heikkila H, Jarvinen M, Saali K, Karhumaki L. The effect of breathing frequency on deposition of drug aerosol using an inhalation-synchronized dosimeter in healthy adults. Clin Physiol 1999;19:269–74
- Lester MK, Flume PA, Gray SL, Anderson D. Bowman CM. Nebulizer use and maintenance by cystic fibrosis patients: a survey study. Respir Care 2004;49:1504–8
- Seeto L, Lim S. Asthma and COPD. Inhalation therapy - clarity or confusion? Aust Fam Physician 2001;30:557–61